Cellomics

The Cellomics Portfolio of LIFE & BRAIN is focused on the rapidly evolving field of iPS cell-based disease modeling and drug discovery. We continuously develop advanced cell products and customized services for CNS applications. Latest developments such as our LB:MiG microglia cells and the microglia platform PhenoMiG extend our Portfolio from neuro-intrinsic to neuroimmunological applications. Together with our partner KSILINK in Strasbourg we exploit multidimensional image- and AI-based phenotyping for screening applications.

Our R&D activities benefit from close interaction with the Institute of Reconstructive Neurobiology at the Bonn University Hospital and participation as SME partner in international research consortia.

In a time of quick comes-and-goes and overhasted catalogue launches, we take pride in offering robust quality-controlled products evolving from academic excellence and in caring about individual customers’ requirements.